High end GPCR design: crafted ligand design and druggability analysis using protein structure, lipophilic hotspots and explicit water networks
Tóm tắt
G Protein-Coupled Receptors (GPCRs) are a large family of therapeutically important proteins and as diverse X-ray structures become available it is increasingly possible to leverage structural information for rational drug design. We present herein approaches that use explicit water networks combined with energetic surveys of the binding site (GRID), providing an enhanced druggability and ligand design approach, with structural understanding of ligand binding, including a ‘magic’ methyl and binding site mutations, and a fast new approach to generate and score waters. The GRID program was used to identify lipophilic and hydrogen bonding hotspots. Explicit full water networks were generated and scored for (pseudo)apo structures and ligand-protein complexes using a new approach, WaterFLAP (Molecular Discovery), together with WaterMap (Schrödinger) for (pseudo)apo structures. A scoring function (MetaScore) was developed using a fast computational protocol based on several short adiabatic biased MD simulations followed by multiple short well-tempered metadynamics runs. Analysis of diverse ligands binding to the adenosine A2A receptor together with new structures for the δ/κ/μ opioid and CCR5 receptors confirmed the key role of lipophilic hotspots in driving ligand binding and thus design; the displacement of ‘unhappy’ waters generally found in these regions provides a key binding energy component. Complete explicit water networks could be robustly generated for protein-ligand complexes using a WaterFLAP based approach. They provide a structural understanding of structure-activity relationships such as a ‘magic methyl’ effect and with the metadynamics approach a useful estimation of the binding energy changes resulting from active site mutations. The promise of full structure-based drug design (SBDD) for GPCRs is now possible using a combination of advanced experimental and computational data. The conformational thermostabilisation of StaR® proteins provide the ability to easily generate biophysical screening data (binding including fragments, kinetics) and to get crystal structures with both potent and weak ligands. Explicit water networks for apo and ligand-complex structures are a critical ‘third dimension’ for SBDD and are key for understanding ligand binding energies and kinetics. GRID lipophilic hotspots are found to be key drivers for binding. In this context ‘high end’ GPCR ligand design is now enabled.
Tài liệu tham khảo
Abel R, Salam NK, Shelley J, Farid R, Friesner RA, Sherman W: Contribution of Explicit Solvent Effects to the Binding Affinity of Small-Molecule Inhibitors in Blood Coagulation Factor Serine Proteases. ChemMedChem 2011, 6: 1049–1066. 10.1002/cmdc.201000533
Ballesteros JA, Weinstein H, Stuart CS: Methods in Neurosciences. Academic, New York; 1995:366–428.
Barducci A, Bussi G, Parrinello M: Well-Tempered Metadynamics: A Smoothly Converging and Tunable Free-Energy Method. Physical review letters 2008, 100: 020603.
Baroni M, Cruciani G, Sciabola S, Perruccio F, Mason JS: A Common Reference Framework for Analyzing/Comparing Proteins and Ligands. Fingerprints for Ligands and Proteins (FLAP): Theory and Application. J Chem Inf Model 2007, 47: 279–294. 10.1021/ci600253e
Berendsen HJ, Postma JP, van Gunsteren WF, DiNola ARHJ, Haak JR: Molecular Dynamics With Coupling to an External Bath. J Chem Phys 1984, 81: 3684. 10.1063/1.448118
Bertheleme N, Chae PS, Singh S, Mossakowska D, Hann MM, Smith KJ, Hubbard JA, Dowell SJ, Byrne B: Unlocking the Secrets of the Gatekeeper: Methods for Stabilizing and Crystallizing GPCRs. Biochim Biophys Acta 2013, 1828: 2583–2591. 10.1016/j.bbamem.2013.07.013
Beuming T, Che Y, Abel R, Kim B, Shanmugasundaram V, Sherman W: Thermodynamic Analysis of Water Molecules at the Surface of Proteins and Applications to Binding Site Prediction and Characterization. Proteins 2012, 80: 871–883. 10.1002/prot.23244
Bortolato A, Tehan BG, Bodnarchuk MS, Essex JW, Mason JS: Water Network Perturbation in Ligand Binding: Adenosine A(2A) Antagonists As a Case Study. J Chem Inf Model 2013, 53: 1700–1713. 10.1021/ci4001458
Breiten B, Lockett MR, Sherman W, Fujita S, Al-Sayah M, Lange H, Bowers CM, Heroux A, Krilov G, Whitesides GM: Water Networks Contribute to Enthalpy/Entropy Compensation in Protein-Ligand Binding. J Am Chem Soc 2013,135(41):15579–15584. 10.1021/ja4075776
Bussi G, Donadio D, Parrinello M: Canonical Sampling Through Velocity Rescaling. J Chem Phys 2007, 126: 014101. 10.1063/1.2408420
Congreve M, Andrews SP, Dore AS, Hollenstein K, Hurrell E, Langmead CJ, Mason JS, Ng IW, Tehan B, Zhukov A, Weir M, Marshall FH: Discovery of 1,2,4-Triazine Derivatives As Adenosine A(2A) Antagonists Using Structure Based Drug Design. J Med Chem 2012, 55: 1898–1903. 10.1021/jm201376w
Congreve M, Langmead CJ, Mason JS, Marshall FH: Progress in Structure Based Drug Design for G Protein-Coupled Receptors. J Med Chem 2011, 54: 4283–4311. 10.1021/jm200371q
Darden T, York D, Pedersen L: Particle Mesh Ewald: An Nlog (N) Method for Ewald Sums in Large Systems. J Chem Phys 1993, 98: 10089. 10.1063/1.464397
Dore AS, Robertson N, Errey JC, Ng I, Hollenstein K, Tehan B, Hurrell E, Bennett K, Congreve M, Magnani F, Tate CG, Weir M, Marshall FH: Structure of the Adenosine A(2A) Receptor in Complex With ZM241385 and the Xanthines XAC and Caffeine. Structure 2011, 19: 1283–1293. 10.1016/j.str.2011.06.014
FLAP/WaterFLAP: Molecular Discovery Ltd. Pinner, UK; 2013.
Goodford PJ: A Computational Procedure for Determining Energetically Favorable Binding Sites on Biologically Important Macromolecules. J Med Chem 1985, 28: 849–857. 10.1021/jm00145a002
Hollenstein K, Kean J, Bortolato A, Cheng RK, Dore AS, Jazayeri A, Cooke RM, Weir M, Marshall FH: Structure of Class B GPCR Corticotropin-Releasing Factor Receptor 1. Nature 2013, 499: 438–443. 10.1038/nature12357
Jakalian A, Jack DB, Bayly CI: Fast, Efficient Generation of High Quality Atomic Charges. AM1 - BCC Model: II. Parameterization and Validation. J Comput Chem 2002, 23: 1623–1641. 10.1002/jcc.10128
Kobilka B: The Structural Basis of G-Protein-Coupled Receptor Signaling (Nobel Lecture). Angew Chem Int Ed Engl 2013, 52: 6380–6388. 10.1002/anie.201302116
Langmead CJ, Andrews SP, Congreve M, Errey JC, Hurrell E, Marshall FH, Mason JS, Richardson CM, Robertson N, Zhukov A, Weir M: Identification of Novel Adenosine A(2A) Receptor Antagonists by Virtual Screening. J Med Chem 2012, 55: 1904–1909. 10.1021/jm201455y
Lindorff-Larsen K, Piana S, Palmo K, Maragakis P, Klepeis JL, Dror RO, Shaw DE: Improved Side-Chain Torsion Potentials for the Amber Ff99SB Protein Force Field. Proteins 2010, 78: 1950–1958.
Lunn G, Banks BJ, Crook R, Feeder N, Pettman A, Sabnis Y: Discovery and Synthesis of a New Class of Opioid Ligand Having a 3-Azabicyclo[3.1.0]Hexane Core. An Example of a ‘Magic Methyl’ Giving a 35-Fold Improvement in Binding. Bioorg Med Chem Lett 2011, 21: 4608–4611. 10.1016/j.bmcl.2011.05.132
Maestro 92: Schrödinger LLC. New York, NY; 2011.
Marchi M, Ballone P: Adiabatic Bias Molecular Dynamics: A Method to Navigate the Conformational Space of Complex Molecular Systems. J Chem Phys 1999, 110: 3697. 10.1063/1.478259
Mason JS, Bortolato A, Congreve M, Marshall FH: New Insights From Structural Biology into the Druggability of G Protein-Coupled Receptors. Trends Pharmacol Sci 2012, 33: 249–260. 10.1016/j.tips.2012.02.005
Parrinello M, Rahman A: Polymorphic Transitions in Single Crystals: A New Molecular Dynamics Method. J Appl Phys 1981, 52: 7182. 10.1063/1.328693
Pearlstein RA, Sherman W, Abel R: Contributions of Water Transfer Energy to Protein-Ligand Association and Dissociation Barriers: WaterMap Analysis of a Series of P38alpha MAP Kinase Inhibitors. Proteins 2013, 81: 1509–1526. 10.1002/prot.24276
Provasi D, Bortolato A, Filizola M: Exploring Molecular Mechanisms of Ligand Recognition by Opioid Receptors With Metadynamics. Biochemistry 2009, 48: 10020–10029. 10.1021/bi901494n
Provasi D, Filizola M: Putative Active States of a Prototypic G-Protein-Coupled Receptor From Biased Molecular Dynamics. Biophys J 2010, 98: 2347–2355. 10.1016/j.bpj.2010.01.047
Sciabola S, Stanton RV, Mills JE, Flocco MM, Baroni M, Cruciani G, Perruccio F, Mason JS: High-Throughput Virtual Screening of Proteins Using GRID Molecular Interaction Fields. J Chem Inf Model 2010, 50: 155–169. 10.1021/ci9003317
Siu FY, He M, de GC, Han GW, Yang D, Zhang Z, Zhou C, Xu Q, Wacker D, Joseph JS, Liu W, Lau J, Cherezov V, Katritch V, Wang MW, Stevens RC: Structure of the Human Glucagon Class B G-Protein-Coupled Receptor. Nature 2013, 499: 444–449. 10.1038/nature12393
Snyder PW, Mecinovic J, Moustakas DT, Thomas SW 3rd, Harder M, Mack ET, Lockett MR, Héroux A, Sherman W, Whitesides GM: Mechanism of the Hydrophobic Effect in the Biomolecular Recognition of Arylsulfonamides by Carbonic Anhydrase. Proc Natl Acad Sci U S A 2011,108(44):17889–17894. 10.1073/pnas.1114107108
Sousa da Silva AW, Vranken WF: ACPYPE - AnteChamber PYthon Parser InterfacE. BMC Res Notes 2012, 5: 367. 10.1186/1756-0500-5-367
Tan Q, Zhu Y, Li J, Chen Z, Han GW, Kufareva I, Li T, Ma L, Fenalti G, Li J, Zhang W, Xie X, Yang H, Jiang H, Cherezov V, Liu H, Stevens RC, Zhao Q, Wu B: Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex. Science 2013, 341: 1387–1390. 10.1126/science.1241475
Wang C, Wu H, Katritch V, Han GW, Huang XP, Liu W, Siu FY, Roth BL, Cherezov V, Stevens RC: Structure of the Human Smoothened Receptor Bound to an Antitumour Agent. Nature 2013, 497: 338–343. 10.1038/nature12167
Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA: Development and Testing of a General Amber Force Field. J Comput Chem 2004, 25: 1157–1174. 10.1002/jcc.20035
Wang L, Berne BJ, Friesner RA: Ligand Binding to Protein-Binding Pockets With Wet and Dry Regions. Proc Natl Acad Sci U S A 2011, 108: 1326–1330. 10.1073/pnas.1016793108
WaterMap: Schrödinger LLC. New York, NY; 2013.
Wu B, Chien EY, Mol CD, Fenalti G, Liu W, Katritch V, Abagyan R, Brooun A, Wells P, Bi FC, Hamel DJ, Kuhn P, Handel TM, Cherezov V, Stevens RC: Structures of the CXCR4 Chemokine GPCR With Small-Molecule and Cyclic Peptide Antagonists. Science 2010, 330: 1066–1071. 10.1126/science.1194396
Zhukov A, Andrews SP, Errey JC, Robertson N, Tehan B, Mason JS, Marshall FH, Weir M, Congreve M: Biophysical Mapping of the Adenosine A2A Receptor. J Med Chem 2011, 54: 4312–4323. 10.1021/jm2003798